Julie Jeanes

Julie Jeanes currently serves as the Executive Director and Global Team Leader at Daiichi Sankyo, Inc., a position held since November 2022. Prior experience includes serving as Senior Director and US Medical Lead for the Melanoma, Relatlimab, and Bempegaldesleukin Programs at Bristol Myers Squibb from April 2021 to November 2022, and holding various senior roles at Celgene between December 2013 and April 2021, including Senior Director of Strategic Planning for Global Medical Affairs. Julie also worked at Novartis as an Expert Clinical Manager and Senior Clinical Manager from August 2010 to December 2013. Earlier career roles include positions at TKL Research, Rutgers University, Walgreens Pharmacy, and Children's Hospital Boston. Education was completed at the Massachusetts College of Pharmacy and Health Sciences.